Europe: precision medicine and access to NGS cancer biomarker testing Precision medicine and access to NGS cancer biomarker… Centralised Diagnostics (CEDx) | In-vitro diagnostics | Molecular Diagnostics (MDx) | Next Generation Sequencing (NGS) | Tissue Diagnostics (TDx) | Europe | IVD Gateway | LabPRO Plus | Molecular Diagnostics (MDx) | Next Generation Sequencing (NGS) | Tissue Diagnostics (TDx)
Proportion of cancer biomarker testing done with NGS expected to double in 2022 compared to 2019 Proportion of cancer biomarker testing done with NGS… Centralised Diagnostics (CEDx) | In-vitro diagnostics | Molecular Diagnostics (MDx) | Point-of-care testing (POCT) | Tissue Diagnostics (TDx) | Europe | IVD Gateway | LabPRO Plus | Molecular Diagnostics (MDx) | Next Generation Sequencing (NGS) | Tissue Diagnostics (TDx)
Minimally invasive surgery device market in Latin America: four areas to watch The choice for traditional open surgery is becoming less… General surgery | Minimally invasive surgery | Surgical device | Americas | Minimally invasive surgery | Surgical Gateway
Insights into Europe’s covid-19 testing and technology use 2021-2022: PCR v serology v antigen Europe is shifting its covid-19-approach from pandemic to… Centralised Diagnostics (CEDx) | Covid-19 testing | In-vitro diagnostics | Molecular Diagnostics (MDx) | Europe | IVD Gateway | Molecular Diagnostics (MDx)
Watch on-demand: Will Covid-19 Accelerate the Next Wave of Adoption of Next-Generation Sequencing (NGS) in Healthcare? Now, sequencing looks set to become even more integral in… Covid-19 testing | In-vitro diagnostics | Next Generation Sequencing (NGS) | Uncategorised | Global | IVD Gateway | Next Generation Sequencing (NGS)
The fastest-growing areas for LATAM’s next-generation sequencing market The next-generation sequencing (NGS) market is expected to… In-vitro diagnostics | Next Generation Sequencing (NGS) | Americas | IVD Gateway | Next Generation Sequencing (NGS)
The fastest-growing areas for APAC’s next-generation sequencing market The next-generation sequencing (NGS) market is expected to… In-vitro diagnostics | Next Generation Sequencing (NGS) | Asia | IVD Gateway | Next Generation Sequencing (NGS)
TAVR Japan: A third of procedures carried out in small and mid-sized hospitals Transcatheter aortic valve replacements (TAVR) is set to be… Cardiovascular surgery | Minimally invasive surgery | Surgical device | Asia | Cardiovascular Surgery | Minimally invasive surgery | Surgical Gateway
TAVR bioprosthetic heart valve market to grow between 20-25% in east Asia Transcatheter aortic valve replacements (TAVR) is set to be… Cardiovascular surgery | Minimally invasive surgery | Surgical device | Asia | Cardiovascular Surgery | Minimally invasive surgery | Surgical Gateway
Key domestic market players shaping the future of TAVR in China Access to Transcatheter aortic valve replacements (TAVR)… Cardiovascular surgery | Minimally invasive surgery | Surgical device | Asia | Cardiovascular Surgery | Minimally invasive surgery | Surgical Gateway
2022 healthcare megatrends shaping IVD 2022 healthcare megatrends shaping IVD… In-vitro diagnostics | Molecular Diagnostics (MDx) | Next Generation Sequencing (NGS) | Point-of-care testing (POCT) | Asia | Europe | Middle East & Africa | IVD Gateway | Molecular Diagnostics (MDx) | Next Generation Sequencing (NGS) | Point-of-care testing (POCT)
2022 healthcare megatrends shaping the surgical-device sector This infographic looks at three trends in healthcare that… General surgery | Minimally invasive surgery | Orthopaedic & Spine Surgery | Surgical device | Asia | Europe | Middle East & Africa | Cardiovascular Surgery | Minimally invasive surgery | Orthopaedic & Spine Surgery | Robotic surgery | Surgical Gateway | Urology